首页> 外文会议>International Mass Spectrometry Conference >Quantitation of MET using Mass Spectrometry for Clinical Application: Correlation with IHC and MET Gene Amplification in FFPE Tumor Tissue
【24h】

Quantitation of MET using Mass Spectrometry for Clinical Application: Correlation with IHC and MET Gene Amplification in FFPE Tumor Tissue

机译:用质谱法定量临床应用:与IHC的相关性,并在FFPE肿瘤组织中得到基因扩增

获取原文

摘要

The OncoPlexDx multiplexed assay measures the absolute level of MET and the other targets in clinical tumor FFPE tissue with high precision. Compared to IHC, SRM provided a quantitative and linear measurement of MET expression, reliably distinguishing between non-amplified and amplified MET tumors at a cut-off point of >1500 amol/ug.
机译:oncoplexdx多路复用测定测量临床肿瘤FFPE组织的绝对水平和高精度。与IHC相比,SRM提供了MET表达的定量和线性测量,可靠地区分在> 1500AMOL / UG的截止点处的非扩增和扩增的态肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号